Transcranial sonography in differential diagnosis of Parkinson disease and other movement disorders

被引:1
|
作者
Wang Li-Shu
Yu Teng-Fei
Chai Bin
He Wen
机构
[1] Beijing Tiantan Hospital
[2] China
[3] Capital Medical University
[4] Department of Ultrasound
[5] Department of Neurology
[6] Beijing 100070
基金
中国国家自然科学基金;
关键词
Transcranial sonography; Movement disorders; Parkinson disease;
D O I
暂无
中图分类号
R742.5 [震颤麻痹综合征];
学科分类号
1002 ;
摘要
Background: Reports evaluating the efficacy of transcranial sonography (TCS) for the differential diagnosis of Parkinson disease (PD) and other movement disorders in China are scarce. Therefore, this study aimed to assess the application of TCS for the differential diagnosis of PD, multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and essential tremor (ET) in Chinese individuals.Methods: From 2017 to 2019, 500 inpatients treated at the Department of Dyskinesia, Beijing Tiantan Hospital, Capital Medical University underwent routine transcranial ultrasound examination. The cross-sections at the midbrain and thalamus levels were scanned, and the incidence rates of substantia nigra (SN) positivity and the incidence rates of lenticular hyperechoic area were recorded. The echo of the SN was manually measured.Results: Of the 500 patients, 125 were excluded due to poor signal in temporal window sound transmission. Among the 375 individuals with good temporal window sound transmission, 200 were diagnosed with PD, 90 with ET, 50 with MSA, and 35 with PSP. The incidence rates of SN positivity differed significantly among the four patient groups (χ2 = 121.061,P < 0.001). Between-group comparisons were performed, and the PD group showed a higher SN positivity rate than the ET (χ2 = 94.898,P < 0.017), MSA (χ2 = 57.619,P < 0.017), and PSP (χ2 = 37.687,P < 0.017) groups. SN positivity showed a good diagnostic value for differentiating PD from the other three movement diseases, collectively or individually. The incidences of lenticular hyperechoic area significantly differed among the four patient groups (χ2 = 38.904,P < 0.001). Next, between-group comparisons were performed. The lenticular hyperechoic area was higher in the PD group than in the ET (χ2 = 6.714,P < 0.017) and MSA (χ2= 18.680,P < 0.017) groups but lower than that in the PSP group (χ2 = 0.679,P > 0.017).Conclusion: SN positivity could effectively differentiate PD from ET, PSP, and MSA in a Chinese population.
引用
收藏
页码:1726 / 1731
页数:6
相关论文
共 50 条
  • [41] Sleep disorders in Parkinson's disease and other movement disorders
    Clavero, P.
    Rodriguez-Oroz, M. C.
    ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2007, 30 : 143 - 153
  • [42] Apomorphine in the treatment of Parkinson disease and other movement disorders
    Gunzler, Steven A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (06) : 1027 - 1038
  • [43] Transcranial B-Mode Sonography in Movement Disorders
    Yilmaz, Rezzak
    Berg, Daniela
    IMAGING IN MOVEMENT DISORDERS: IMAGING APPLICATIONS IN NON-PARKINSONIAN AND OTHER MOVEMENT DISORDERS, 2018, 143 : 179 - 212
  • [44] Transcranial Sonography in Parkinson's Disease and Parkinsonism
    Lee, Won Yong
    Kim, Ji Youn
    Kim, Seong Tae
    JOURNAL OF MOVEMENT DISORDERS, 2008, 1 (01) : 6 - 12
  • [45] Transcranial sonography in parkinson's disease and parkinsonism
    Durmaz, Seyma
    Kursun, Oguzhan
    Oztekin, Nese
    Karadag, Yesim
    NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY, 2023, 40 (04): : 200 - 206
  • [46] Parkinson's disease detected by transcranial sonography
    Bartova, P.
    Skoloudik, D.
    Fadrna, I.
    Herzig, R.
    Kanovsky, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S182 - S182
  • [47] Brain parenchyma sonography for early and differential diagnosis of Parkinson's disease
    Walter, U
    Dressler, D
    Benecke, R
    AKTUELLE NEUROLOGIE, 2004, 31 (07) : 325 - 332
  • [48] Transcranial Sonography Based Diagnosis Of Parkinson's Disease Via Cascaded Kernel RVFL
    Xue, Zeyu
    Shi, Jun
    Dai, Yakang
    Dong, Yun
    Zhang, Qi
    Zhang, Yingchun
    2018 40TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2018, : 574 - 577
  • [49] Amantadine in the treatment of Parkinson's disease and other movement disorders
    Rascol, Olivier
    Fabbri, Margherita
    Poewe, Werner
    LANCET NEUROLOGY, 2021, 20 (12): : 1048 - 1056
  • [50] Current concepts in Parkinson's disease and other movement disorders
    Jankovic, Joseph
    CURRENT OPINION IN NEUROLOGY, 2012, 25 (04) : 429 - 432